Cargando…

Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis

BACKGROUND: This research is aimed to explore mortality patterns and quantitatively assess the risks of cardiovascular mortality (CVM) in patients with primary gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). METHODS: We extracted data from the Surveillance, Epidemiology, and End Results...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shenghong, Wang, Wei, He, Chiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257376/
https://www.ncbi.nlm.nih.gov/pubmed/34257826
http://dx.doi.org/10.1155/2021/9985814
_version_ 1783718300179496960
author Sun, Shenghong
Wang, Wei
He, Chiyi
author_facet Sun, Shenghong
Wang, Wei
He, Chiyi
author_sort Sun, Shenghong
collection PubMed
description BACKGROUND: This research is aimed to explore mortality patterns and quantitatively assess the risks of cardiovascular mortality (CVM) in patients with primary gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). METHODS: We extracted data from the Surveillance, Epidemiology, and End Results (SEER) database for patients diagnosed with GEP-NENs between 2000 and 2015. The standardized mortality ratio (SMR) and the absolute excess risk were obtained based on the reference of the general US population. The cumulative incidence function curves were constructed for all causes of death. Predictors for CVM were identified using a multivariate competing risk model. RESULTS: Overall, 42027 patients were enrolled from the SEER database, of whom 1598 (3.8%) died from cardiovascular disease (CVD). The SMR for CVM was 1.20 (95% CI: 1.14-1.26) among GEP-NEN patients. The cumulative mortality of CVD was the lowest among all causes of death, including primary cancer, other cancer, and other noncancer diseases. Furthermore, age at diagnosis, race, Hispanic origin, sex, marital status, year of diagnosis, grade, education level, region, SEER stage, primary site, surgery, and chemotherapy were identified as independent predictors of CVM in GEP-NEN patients. CONCLUSIONS: GEP-NEN patients have a significantly increased risk of CVM relative to the general population. Cardioprotective interventions might be considered a preferred method for these patients.
format Online
Article
Text
id pubmed-8257376
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82573762021-07-12 Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis Sun, Shenghong Wang, Wei He, Chiyi Oxid Med Cell Longev Research Article BACKGROUND: This research is aimed to explore mortality patterns and quantitatively assess the risks of cardiovascular mortality (CVM) in patients with primary gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). METHODS: We extracted data from the Surveillance, Epidemiology, and End Results (SEER) database for patients diagnosed with GEP-NENs between 2000 and 2015. The standardized mortality ratio (SMR) and the absolute excess risk were obtained based on the reference of the general US population. The cumulative incidence function curves were constructed for all causes of death. Predictors for CVM were identified using a multivariate competing risk model. RESULTS: Overall, 42027 patients were enrolled from the SEER database, of whom 1598 (3.8%) died from cardiovascular disease (CVD). The SMR for CVM was 1.20 (95% CI: 1.14-1.26) among GEP-NEN patients. The cumulative mortality of CVD was the lowest among all causes of death, including primary cancer, other cancer, and other noncancer diseases. Furthermore, age at diagnosis, race, Hispanic origin, sex, marital status, year of diagnosis, grade, education level, region, SEER stage, primary site, surgery, and chemotherapy were identified as independent predictors of CVM in GEP-NEN patients. CONCLUSIONS: GEP-NEN patients have a significantly increased risk of CVM relative to the general population. Cardioprotective interventions might be considered a preferred method for these patients. Hindawi 2021-06-26 /pmc/articles/PMC8257376/ /pubmed/34257826 http://dx.doi.org/10.1155/2021/9985814 Text en Copyright © 2021 Shenghong Sun et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sun, Shenghong
Wang, Wei
He, Chiyi
Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title_full Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title_fullStr Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title_full_unstemmed Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title_short Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
title_sort cardiovascular mortality risk among patients with gastroenteropancreatic neuroendocrine neoplasms: a registry-based analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257376/
https://www.ncbi.nlm.nih.gov/pubmed/34257826
http://dx.doi.org/10.1155/2021/9985814
work_keys_str_mv AT sunshenghong cardiovascularmortalityriskamongpatientswithgastroenteropancreaticneuroendocrineneoplasmsaregistrybasedanalysis
AT wangwei cardiovascularmortalityriskamongpatientswithgastroenteropancreaticneuroendocrineneoplasmsaregistrybasedanalysis
AT hechiyi cardiovascularmortalityriskamongpatientswithgastroenteropancreaticneuroendocrineneoplasmsaregistrybasedanalysis